Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Commentary Volume 6 Issue 1

n-Covid Drugs and their Relevance in Present Day Scenario

D Narsimhaswamy1, Kurra Mohan2 and Ravi Varala3*

112001, Belcher Rd S; Apt No: N226, Largo Florida, USA
2Department of Pharmaceutical Chemistry, Telangana University, Nizamabad, Telangana, India
3Scrips Pharma, Mallapur, Hyderabad, Telangana, India

*Corresponding Author: Ravi Varala, Scrips Pharma, Mallapur, Hyderabad, Telangana, India.

Received: November 30, 2021; Published: December 20, 2021


This commentary briefly discusses the necessity of utilizing repurposed drugs/vaccines to combat against evil covid-19. As new variants are (such as Omicron) emerging out due to undergoing mutations by virus, urge of developing more efficient drugs is necessary both in terms of efficacy and safety.

Keywords: n-Covid; Vaccines; Efficacy; Safety; Mutations; Variants; Drugs; Repurpose


  1. Zhu N., et al. The New England Journal of Medicine 8 (2020): 727-733.
  3. Varala R., et al. Coronaviruses 1 (2020): 9-12.
  4. Varala R., et al. Research Journal of Chemical Sciences 1 (2021): 84-86.
  5. Varala R., et al. Caribbean Journal of Science and Technology 1 (2021): 9-12.
  6. Swee Li., et al. Mini-Reviews in Medicinal Chemistry 10 (2021): 1173-1181.
  7. Gokada MR., et al. Journal of Evidence-Based Integrative Medicine 26 (2021): 1-8.
  8. Khan M., et al. Molecules1 (2021): 39.


Citation: Ravi Varala., et al. “n-Covid Drugs and their Relevance in Present Day Scenario". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 113-115.


Copyright: © 2022 Ravi Varala., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

Contact US